,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
enhertu could transform #breastcancer treatment, landmark her2-low trial suggests. #asco22
Medscape Oncology provides breaking medical news, references for drugs, diseases, and procedures, and free CME.